ステレオタクシス
STXS
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2026 Q2 | -0.05 | $8M | -$4M |
| 2026 Q1 | -0.06 | $6M | -$4M |
| 2025 Q4 | -0.06 | $9M | -$4M |
| 2025 Q3 | -0.07 | $7M | -$4M |
| 2025 Q2 | -0.05 | $9M | -$4M |
| 2025 Q1 | -0.07 | $7M | -$2M |
| 2024 Q4 |
| -0.09 |
| $6M |
| $1M |
| 2024 Q3 | -0.08 | $9M | -$4M |